| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/26/2010 | US7820374 Determining a DNA lesion in a eukaryotic cell; use in diagnosis of diseases |
| 10/26/2010 | US7820373 determining a risk of a cardiovascular adverse event as a consequence of cardiac stress testing ; measuring in a plasma sample level of placenta growth factor (PIGf); myocardial ischemia, ST-segment change, angina pectoris, myocardial necrosis, myocardial infarction, and stroke |
| 10/26/2010 | US7820372 identifying and measuring the concentration of bio or chemical molecules in a solution by placing a dual-band antenna; using microwave frequency |
| 10/26/2010 | US7820184 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| 10/26/2010 | US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents |
| 10/26/2010 | US7820030 qualitative and quntitative analysis of a target polynucleotides using an electrode having a probe molecule reversibly immobilized with respect to the electrode surface, to obtain and determine, based upon the difference between the first and second electrochemical signal |
| 10/26/2010 | US7819161 Systems and methods for blood glucose sensing |
| 10/26/2010 | US7819007 Shower mat for using resonant acoustic and/or resonant acousto-EM energy to augment bone growth |
| 10/26/2010 | US7819006 Using resonant acoustic and/or resonant acousto-EM energy to augment a function of a structure by applying a magnetic field to amplify the induced acoustic resonance |
| 10/26/2010 | CA2477922C Stabilizing agent for enzymes |
| 10/26/2010 | CA2426398C Methods of modifying eukaryotic cells |
| 10/26/2010 | CA2416602C Nucleotide sequences of a new class of diverged delta-9 stearoyl-acp desaturase genes |
| 10/26/2010 | CA2409698C Neural progenitor cell populations |
| 10/26/2010 | CA2380480C Detection and identification of bacterial strains |
| 10/26/2010 | CA2373250C Measuring caspase 3 activity to determine viral stability |
| 10/26/2010 | CA2366109C Hydrogen peroxide indicator employing enzyme and dye |
| 10/26/2010 | CA2361672C Method for determining the concentration of thrombin inhibitors |
| 10/26/2010 | CA2351887C Psca: prostate stem cell antigen and uses thereof |
| 10/26/2010 | CA2349810C Isometric primer extension method and kit for detection and quantification of specific nucleic acid |
| 10/26/2010 | CA2327349C Il-2 selective agonists and antagonists |
| 10/26/2010 | CA2256089C Energy transfer diagnostic tool and method for detecting a defect in hemostasis |
| 10/26/2010 | CA2197717C Mycobacteria functional screening and/or expression vectors |
| 10/26/2010 | CA2195752C Oligomeric carrier molecules with defined incorporated marker groups andhaptens |
| 10/26/2010 | CA2178941C Transgenic production of antibodies in milk |
| 10/26/2010 | CA2135591C Stabilized oligonucleotides and their use |
| 10/24/2010 | CA2701572A1 Method for manufacturing an enzymatic reagent ink |
| 10/24/2010 | CA2701569A1 Analytical test strips |
| 10/21/2010 | WO2010121238A2 Methods and kits to predict therapeutic outcome of tyrosine kinase inhibitors |
| 10/21/2010 | WO2010121231A1 Methods for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies |
| 10/21/2010 | WO2010121223A2 Electromagnetic molecular sensors and methods of using same |
| 10/21/2010 | WO2010121207A1 Methods and compositions related to the interaction of t-cadherin and adiponectin |
| 10/21/2010 | WO2010121138A2 Compositions and methods for preventing and monitoring disease |
| 10/21/2010 | WO2010121131A2 Quality control bioassays for nutriceutical and medicinal products |
| 10/21/2010 | WO2010121123A1 Methods and gene expression signature for assessing ras pathway activity |
| 10/21/2010 | WO2010120951A1 Diagnostic devices and related methods |
| 10/21/2010 | WO2010120946A1 Improvements in mass spectrum-based identification and quantitation of proteins and peptides |
| 10/21/2010 | WO2010120942A2 Histone modification patterns for clinical diagnosis and prognosis of cancer |
| 10/21/2010 | WO2010120914A1 Predictive models and method for assessing age |
| 10/21/2010 | WO2010120853A2 Methods and compositions to detect and differentiate small rnas in rna maturation pathway |
| 10/21/2010 | WO2010120814A1 Inflammatory bowel disease prognostics |
| 10/21/2010 | WO2010120803A2 Methods and compositions for detection of small rnas |
| 10/21/2010 | WO2010120746A1 Polymorphisms in human trpv4 and methods of use thereof |
| 10/21/2010 | WO2010120727A1 Genetic loci associated with fusarium ear mold resistance in maize |
| 10/21/2010 | WO2010120578A1 Microrna as a biomarker of pancreatic islet beta-cell engagement |
| 10/21/2010 | WO2010120526A2 Methods and systems for screening for and diagnosing dna methylation associated with autism spectrum disorders |
| 10/21/2010 | WO2010120420A1 Delivery of oligonucleotide-functionalized nanoparticles |
| 10/21/2010 | WO2010120374A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof |
| 10/21/2010 | WO2010120364A2 Impedimetric sensors using dielectric nanoparticles |
| 10/21/2010 | WO2010120262A1 Methods and compositions for the treatment of medical conditions involving cellular programming |
| 10/21/2010 | WO2010120143A2 Marker for prognosis of liver cancer |
| 10/21/2010 | WO2010120027A1 Primer for detecting avellino corneal dystrophy |
| 10/21/2010 | WO2010119828A1 Method for culturing bone marrow stromal cells and mesenchymal stem cells, and method for producing graft cells for treating central neurological disease |
| 10/21/2010 | WO2010119819A1 Method of preparing human lung tissue stem cells and method of inducing differentiation into human alveolar epithelial cells |
| 10/21/2010 | WO2010119721A1 Stable artificial bioluminescent enzyme having super-high brightness |
| 10/21/2010 | WO2010119693A1 Method of screening for insulin secretion-potentiating agents |
| 10/21/2010 | WO2010119691A1 Diagnosis and treatment of cancer using anti-tmprss11e antibody |
| 10/21/2010 | WO2010119270A1 Detection of bacteria and fungi |
| 10/21/2010 | WO2010119138A1 Development of fluorescently p-loop labelled kinases for screening of inhibitors |
| 10/21/2010 | WO2010119133A1 Methods and tools for predicting the efficiency of anthracyclines in cancer |
| 10/21/2010 | WO2010119126A2 Diagnostic methods and tools to predict the efficacy of targeted agents against igf-1 pathway activation in cancer |
| 10/21/2010 | WO2010119062A1 Method of determining the activity of pkc-theta |
| 10/21/2010 | WO2010118991A1 Methods for selecting oocytes and competent embryos with high potential for pregnancy outcome |
| 10/21/2010 | WO2010118865A1 System and method for detection of hla variants |
| 10/21/2010 | WO2010118782A1 Methods and tools for predicting the efficiency of anthracyclines in cancer |
| 10/21/2010 | WO2010118559A1 A method for screening cancer |
| 10/21/2010 | WO2010118525A1 Signature of secreted protein isoforms specific to ovarian cancer |
| 10/21/2010 | WO2010118524A1 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof |
| 10/21/2010 | WO2010118520A1 Process for tumour characteristic and marker set identification, tumour classification and marker sets for cancer |
| 10/21/2010 | WO2010096117A3 Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene |
| 10/21/2010 | WO2010081114A3 Oligonucleotide-coated affinity membranes and uses thereof |
| 10/21/2010 | WO2010081107A3 Flexible pipette tips |
| 10/21/2010 | WO2010079919A3 Method for screening matrix metalloproteinase |
| 10/21/2010 | WO2010079335A3 Method for improving biomass yield |
| 10/21/2010 | WO2010077005A3 Mycobacteria-derived polypeptide and polynucleotide, and method of screening anti-mycobacterial agent |
| 10/21/2010 | WO2010072822A3 Preparation and amplification of nucleic acids by means of magnetic particles |
| 10/21/2010 | WO2010068884A3 Methods and systems for direct sequencing of single dna molecules |
| 10/21/2010 | WO2010066885A3 Indexing of nucleic acid populations |
| 10/21/2010 | WO2010065576A3 The antisense transcriptomes of cells |
| 10/21/2010 | WO2010062951A3 Animal model for osteoarthritis and intervertebral disc disease |
| 10/21/2010 | WO2010062775A3 Methods for detecting modification resistant nucleic acids |
| 10/21/2010 | WO2010054004A3 Nucleic acid extraction on curved glass surfaces |
| 10/21/2010 | WO2010053980A3 Dna integrity assay (dia) for cancer diagnostics, using confocal fluorescence spectroscopy |
| 10/21/2010 | WO2010036943A3 Genetic markers for assessing risk of developing bipolar disorder |
| 10/21/2010 | WO2010007391A9 Hexacyanoferrate modified electrode |
| 10/21/2010 | WO2009158606A9 Structure, synthesis, and applications for oligo phenylene ethynylenes |
| 10/21/2010 | WO2009120249A8 Detection of head and neck cancer using hypermethylated gene detection |
| 10/21/2010 | US20100269216 Network population mapping |
| 10/21/2010 | US20100269214 Nucleic Acid Molecules and Other Molecules Associated with Transcription in Plants and Uses Thereof for Plant Improvement |
| 10/21/2010 | US20100269212 Genetic loci associated with fusarium ear rot (fkr) resistance in maize and generation of improved fkr resistant maize inbred lines |
| 10/21/2010 | US20100269183 Micro-rnas that control myosin expression and myofiber identity |
| 10/21/2010 | US20100269181 Method for Identifying and Managing Livestock by Genotype |
| 10/21/2010 | US20100269180 Methods, compositions and transgenic models related to the interaction of t-cadherin and adiponectin |
| 10/21/2010 | US20100268658 Method for collecting, testing and distributing milk |
| 10/21/2010 | US20100268118 System for removal and infusion of body fluid, and method for its operation |
| 10/21/2010 | US20100267941 Irna agents with biocleavable tethers |
| 10/21/2010 | US20100267931 Heterologous expression of neisserial proteins |
| 10/21/2010 | US20100267930 SLO2 and SLO4, Novel Potassium Channel Proteins from Human Brain |
| 10/21/2010 | US20100267825 Treatment of skin damage |
| 10/21/2010 | US20100267804 Differential expression of micrornas in nonfailing versus failing human hearts |
| 10/21/2010 | US20100267803 Regulators Of Fat Metabolism As Anti-Cancer Targets |